More CIN2+ Detection Seen With HPV Catch-Up Screening in Women Aged ≥65
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, July 11, 2023 -- For women aged 65 to 69 years, catch-up human papillomavirus (HPV) screening is associated with higher cervical intraepithelial neoplasia (CIN) grade 2 or worse (CIN2+) detection, according to a study published online July 6 in PLOS Medicine.
Mette Tranberg, Ph.D., from Randers Regional Hospital in Denmark, and colleagues examined the effects of a catch-up HPV test among 65- to 69-year-old women without previous record of HPV-based screening in the last ≥5.5 years in a population-based study. A total of 11,192 eligible women residing in the Central Denmark Region were invited for HPV screening by attending clinician-based sampling or requesting a vaginal self-sampling kit (intervention group), and 33,387 women residing in other regions received standard care, which was the opportunity to have a cervical cytology collected for whatever reason (reference group).
The researchers found that 62.2 percent of women in the intervention group were screened within 12 months from the date of study inclusion, while 2.2 percent had a cervical cytology collected in the reference group. CIN2+ detection was significantly higher in the intervention versus the reference group (3.9 versus 0.3 per 1,000 women).
"The HPV catch-up screening intervention was associated with higher CIN2+ detection as compared to no screening intervention but longer follow-up is necessary to observe if the intervention translates into fewer cervical cancers and deaths in the screened women," the authors write.
One author disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted July 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Vaginal Cancer Incidence Increasing Globally
WEDNESDAY, July 3, 2024 -- The incidence of vaginal cancer is increasing globally, according to a study published online June 25 in BJOG: An International Journal of Obstetrics...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.